Region: Russia
Category: Cardiovascular
Category: Cardiovascular
Russia Cardiovascular
(3 reports matching your criteria)
-
Europe SGLT2 Inhibitors Market Share, Size, Trends, Industry Analysis Report: By Indication [Cardiovascular, Chronic Kidney Disease (CKD), Type 2 Diabetes, and Others], Drug, Distribution Channel, and Country (Germany, France, UK, Italy, Spain, Netherlands, Russia, and Rest of Europe) – Market Forecast, 2024–2032
... Rest of Europe) – Market Forecast, 2024–2032 The Europe SGLT2 inhibitors market size is expected to reach USD 7,629.79 million by 2032, according to a new study by Polaris Market Research. The report “Europe SGLT2 ... Read More
-
Dyslipidemia Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine
... on global dyslipidemia market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dyslipidemia market by segmenting the ... Read More
-
Cardiovascular Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $19.1 and in terms of global GDP, the market was 0.16%. Cardiovascular drugs was the fourth largest segment within the market accounting for 10.0% preceded and followed by central nervous ... Read More